Simulect IV injection 20 mg, manufactured by Novartis Pharma, contains Basiliximab (genetical recombination) and is an injectable drug supplied as 20mg x 1 bottle (YJ code: 6399418D1032). It is an immunosuppressant used to prevent acute organ rejection in renal transplant patients.
Simulect IV injection 20 mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).